Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?

Leukemia, Published online: 04 March 2020; doi:10.1038/s41375-020-0780-6Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?

https://www.nature.com/articles/s41375-020-0780-6

Source: Leukemia - March 3, 2020 Category: Hematology Authors: Adriano Venditti Robert Peter Gale Francesco Buccisano Gert Ossenkoppele Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia